1 Min Read
Nov 8 (Reuters) - Novus Therapeutics Inc
* Novus Therapeutics reports third quarter 2017 results
* Q3 loss per share $0.43 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.